Bipartisan Executive Branch Reform Bill Advances in House
An ambitious bill (pdf) to promote an entire menu of “good government” reforms in the executive branch was endorsed on a bipartisan basis in the House Government Reform Committee today and reported to the full House.
The bill would notably limit the use of “pseudo-classification” markings such as “sensitive but unclassified” and “for official use only” unless they are authorized by statute or regulation. Such markings have been increasingly used by government agencies to restrict public access to unclassified information.
The “Executive Branch Reform Act of 2006,” HR 5112, was introduced by Committee Chairman Tom Davis (R-VA) and Ranking Member Henry Waxman (D-CA), and unanimously supported by the Committee’s members.
Among its various provisions the bill would: end secret meetings between lobbyists and most executive branch officials; enhance protections for national security whistleblowers; and ban covertly sponsored government propaganda.
Improving public awareness of FDA Advisory Committees would improve public trust and deter misinformation related to the approval of medical products.
FAS has been a leading voice for action on this topic, and has developed a compendium of 150+ heat-related federal policy recommendations.
Proposed bills advance research ecosystems, economic development, and education access and move now to the U.S. House of Representatives for a vote
The absence of consistent voting privileges for patient representatives on Advisory Committees hinders representatives from providing an voice on behalf of the community they represent.